Preugschat, Frank and Yao, Chen-Wen and Strauss, James H. (1990) In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. Journal of Virology, 64 (9). pp. 4364-4374. ISSN 0022-538X. http://resolver.caltech.edu/CaltechAUTHORS:PREjvir90
See Usage Policy.
Use this Persistent URL to link to this item: http://resolver.caltech.edu/CaltechAUTHORS:PREjvir90
We have tested the hypothesis that the flavivirus nonstructural protein NS3 is a viral proteinase that generates the termini of several nonstructural proteins by using an efficient in vitro expression system and monospecific antisera directed against the nonstructural proteins NS2B and NS3. A series of cDNA constructs was transcribed by using T7 RNA polymerase, and the RNA was translated in reticulocyte lysates. The resulting protein patterns indicated that proteolytic processing occurred in vitro to generate NS2B and NS3. The amino termini of NS2B and NS3 produced in vitro were found to be the same as the termini of NS2B and NS3 isolated from infected cells. Deletion analysis of cDNA constructs localized the protease domain within NS3 to the first 184 amino acids but did not eliminate the possibility that sequences within NS2B were also required for proper cleavage. Kinetic analysis of processing events in vitro and experiments to examine the sensitivity of processing to dilution suggested that an intramolecular cleavage between NS2A and NS2B preceded an intramolecular cleavage between NS2B and NS3. The data from these expression experiments confirm that NS3 is the viral proteinase responsible for cleavage events generating the amino termini of NS2B and NS3 and presumably for cleavages generating the termini of NS4A and NS5 as well.
|Additional Information:||Copyright © 1990 by the American Society for Microbiology. We thank Richard Kuhn and Ellen Strauss for stimulating discussions and editorial prowess; David Teplow and Tammy Bauer for expertise and assistance with protein sequencing; and Joel Dalrymple for furnishing cells, virus, and hyperimmune antiserum. We also thank A. E. Gorbalenya for communicating results prior to publication. Frank Preugschat gratefully acknowledges the financial support of the Canadian Natural Sciences and Engineering Research Council (NSERC) and Gordon Ross. This work was supported by Public Health Service grant A120612 from the National Institutes of Health and by a grant from the World Health Organization.|
|Usage Policy:||No commercial reproduction, distribution, display or performance rights in this work are provided.|
|Deposited By:||Archive Administrator|
|Deposited On:||11 Apr 2006|
|Last Modified:||26 Dec 2012 08:49|
Repository Staff Only: item control page